immunotherapy converts locally advanced hepatocellular carcinoma into resectable disease
Published 2 years ago • 474 plays • Length 1:03:32Download video MP4
Download video MP3
Similar videos
-
59:11
understanding phenotypic plasticity in hepatocellular carcinoma to mitigate therapy resistance
-
53:45
a second look at immune interventions in liver cancer
-
4:21
the use of immunotherapy in hcc – in depth subgroup analyses and challenges
-
3:35
cancer immunotherapy
-
28:11
hepatocellular carcinoma - molecular approaches to treatment
-
6:31
understanding cholangiocarcinoma
-
47:42
immune therapy in hepatocellular carcinoma
-
11:50
cancer immunotherapy workshop 2021 – focused ultrasound immune impact in liver tumors
-
1:03:06
changing epidemiology of hepatocellular carcinoma
-
59:49
immunotherapy for hepatocellular carcinoma: promises and challenges
-
1:00:58
the role of the hepatocellular carcinoma expediter network in the search for biomarkers and targets
-
58:38
targeting glypican-3 for imaging and therapy for hepatocellular carcinoma
-
8:59
advanced hcc: case discussion on immunotherapy
-
1:03:41
molecular pathogenesis and targeted therapies for hepatocellular carcinoma
-
3:55
the use of immunotherapy in hcc – efficacy and safety
-
12:47
debate 11: locally-advanced hepatocellular carcinoma (hcc) - surgery is optimal
-
59:47
improving immunotherapy strategies for cancers
-
1:05:03
genomics and cancer biomarkers for hcc: potential applications
-
1:10
the impact of immunotherapy and checkpoint inhibition in treating hcc
-
3:10
advancements in immunotherapy for hepatocellular carcinoma
-
3:29
aacr 2023 highlights on advances in the treatment of hepatocellular carcinoma with pierce chow